Pass It On Trial

Home
United States
Nashville, TN
Pass It On Trial

Convalescent plasma clinical trial for COVID-19. This treatment, convalescent plasma, comes from the blood of patients who have recovered from COVID-19.

The Passive Immunity Trial for Our Nation (Pass It On) is a clinical trial looking to see if a potential treatment, convalescent plasma, might help patients who are sick and hospitalized with COVID-19 recover faster. These patients have developed antibodies that help fight the virus and will be given to sick patients who are in the hospital. Participation in this research study is completely voluntary and it is taking place in 30 sites across the United States.

10/06/2022

Los participantes en el estudio Pass It On procedían de diferentes orígenes raciales y étnicos. La diversidad entre los participantes del estudio es importante y ayuda a los investigadores a saber que lo aprendido en el estudio se aplica a diferentes grupos demográficos.

Para más información visite, passitonstudy.org/resultados

10/05/2022

The findings of the Pass It On study give researchers evidence that using convalescent plasma to treat hospitalized COVID-19 patients is unlikely to be helpful.

These findings were consistent with the December 2021 announcement from the World Health Organization (WHO) that now recommends against the use of convalescent plasma for treating COVID-19, since there is no benefit.

As the pandemic continues, it is important to search for safe and effective treatments against the virus.

Learn about the Pass It On study findings at passitonstudy.org/results

10/01/2022

The Pass It On study was a clinical trial looking to see if convalescent plasma was an effective treatment for unvaccinated patients hospitalized with COVID-19.

The results from the Pass It On study showed there was no benefit to using convalescent plasma to treat patients hospitalized with COVID-19.

As the pandemic continues, it is important to search for safe and effective treatments against the virus.

Learn about the Pass It On study findings at passitonstudy.org/results

09/30/2022

El estudio clínico Pass It On fue un estudio clínico para ver si el plasma convaleciente ayudaba a los pacientes con COVID-19 a recuperarse más rápido. Pacientes hospitalizados con COVID-19 entre 20 y 97 años participaron en el estudio Pass It On en 26 localidades en los Estados Unidos.

Para más información visite, passitonstudy.org/resultados

09/26/2022

Many new medications and treatments have been studied to see if they help people with COVID-19 recover faster. The Pass It On study was a clinical trial looking to see if convalescent plasma was an effective treatment for unvaccinated patients hospitalized with COVID-19. The results of this trial showed that plasma was not helpful for patients hospitalized with COVID-19.

To learn more about the results of the trial please visit, https://passitonstudy.org/results/

09/14/2022

The Pass It On study was committed to partnering with communities to help raise awareness about the trial. The study engaged with over 1,700 community organizations from across the US.
Their support provided diverse communities with information about the trial.

Learn about the Pass It On study results at passitonstudy.org/results/

09/12/2022

El estudio Pass It On se llevó a cabo en 26 localidades en los Estados Unidos. El plasma convaleciente se administró a pacientes hospitalizados con COVID-19 para ver si les ayudaba a recuperarse más rápido del virus.

Los resultados del estudio Pass It On mostraron que no hubo ningún beneficio en el uso de plasma convaleciente en pacientes hospitalizados con COVID-19.

El uso the plasma convaleciente en pacientes hospitalizados con COVID-19,
> No disminuyó el riesgo de muerte.
> No mejoró la recuperación,
> No fue perjudicial ni útil.

Para más información visite, passitonstudy.org/resultados

09/01/2022

Jessica’s daughter joined the Pass It On study to help advance COVID-19 research.

The information learned from this study will help physicians be able to better treat patients who are sick with COVID-19.

Learn about the Pass It On study results at passitonstudy.org/results

08/30/2022

Belinda, a participant in Pass It On, joined the study because she was sick and wanted to make a difference.

With the help of participants like Belinda, the Pass It On study learned that using convalescent plasma to treat hospitalized COVID-19 patients is neither helpful nor harmful.

Learn about the Pass It On study results at passitonstudy.org/results/

08/24/2022

The Pass It On study took place at 26 hospitals and research universities across the United States.

Learn about the Pass It On study results at passitonstudy.org/results/

08/23/2022

Los resultados del estudio clínico Pass It On brindan a los investigadores evidencia de que es poco probable que el uso de plasma convaleciente para tratar pacientes hospitalizados con COVID-19 sea útil.

Estos resultados fueron consistentes con el reporte publicado en diciembre 2021 de la Organización Mundial de Salud (OMS) que ahora recomienda no usar plasma convaleciente para tratar COVID-19.

A medida que continúa la pandemia, sigue siendo importante buscar tratamientos seguros y efectivos contra el virus.

Para más información visite, passitonstudy.org/resultados

08/19/2022

The Pass It On study was a clinical trial to see if convalescent plasma was an effective treatment for patients hospitalized with COVID-19.

Learn about the Pass It On study results at passitonstudy.org/results/

Address

1211 Medical Center Drive
Nashville, TN
37232

Telephone

+16153438010

Website

https://passitonstudy.org/

Alerts

Be the first to know and let us send you an email when Pass It On Trial posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Pass It On Trial:

Shortcuts

Want your practice to be the top-listed Clinic in Nashville?

A research study on convalescent plasma to treat hospitalized COVID-19 patients

Vanderbilt University Medical Center is leading a research study to determine if convalescent plasma is an effective treatment for patients who are hospitalized with COVID-19.

The Passive Immunity Trial for Our Nation (Pass It On) is a clinical trial testing a treatment for COVID-19 patients who are hospitalized. This treatment, convalescent plasma, comes from the blood of patients who have recovered from COVID-19. These patients have developed antibodies that help fight the virus and will be given to sick patients who are in the hospital. Participation in this research study is completely voluntary.

This study is currently enrolling 1,000 patients at 50 locations around the United States. Study participants may see an improvement in their condition, including survival, faster recovery time, or less need for intensive care. Society may benefit as well from learning more about the use of convalescent plasma to treat COVID-19.

Essential workers, racial and ethnic minorities, and those with underlying health conditions are being impacted the most by COVID-19. It is crucial that researchers find a treatment that helps everyone, especially people most affected by this virus.